Amino Acids

, Volume 36, Issue 4, pp 717–724

In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma

  • G. Di Giacomo
  • A. Lentini
  • S. Beninati
  • M. Piacentini
  • C. Rodolfo
Original Article

DOI: 10.1007/s00726-008-0119-5

Cite this article as:
Di Giacomo, G., Lentini, A., Beninati, S. et al. Amino Acids (2009) 36: 717. doi:10.1007/s00726-008-0119-5

Abstract

One of the most relevant problems in tumour treatment resides on the ability of the tumour to form metastasis and disseminate among the organism. The formation of metastases is a complex process, which requires the action of various effectors, not yet completely identified. The analysis of various types of tumours revealed a complex picture about the relationship between type 2 transglutaminase (TG2) expression and outcome and/or metastatic potential of the tumour itself. In some tumours, the transition to a highly invasive state is paralleled by an up-regulation of TG2 expression and/or activity while in some other a down-regulation has been reported. In addition, host tissues seem to react to tumour invasion by up-regulating TG2 expression. In order to analyse whether TG2 might be involved in the metastatic process in melanoma, we studied the metastases formation and development by means of the B16-F10 murine melanoma cell line and with TG2−/− mice as experimental model. Our results indicate that TG2 absence in the host is a favouring condition for the formation and development of the metastasis, while the presence of TG2 in the tumour’s cell might be requested for the development of the metastasis.

Keywords

Transglutaminase 2 Melanoma B16-F10 Metastasis 

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • G. Di Giacomo
    • 1
  • A. Lentini
    • 1
  • S. Beninati
    • 1
  • M. Piacentini
    • 1
    • 2
  • C. Rodolfo
    • 1
  1. 1.Department of BiologyUniversity of Rome Tor VergataRomeItaly
  2. 2.INMI-L. SpallanzaniRomeItaly